Vizeacoumar lab - Cell Genom paper
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer
Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells
Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action.
Focal Adhesion Kinase Alleviates Simulated Microgravity-Induced Inhibition of Osteoblast Differentiation by Activating Transcriptional Wnt/β-Catenin-BMP2-COL1 and Metabolic SIRT1-PGC-1α-CPT1A Pathways
Molecular basis and pathways of the Yin-Yang theory in T cell immunity
MEMO1 binds iron and modulates iron homeostasis in cancer cells
DDX41: exploring the roles of a versatile helicase
Helicases in R-loop Formation and Resolution
BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1
Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy